<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Eur J Clin Microbiol Infect Dis</journal-id>
      <journal-title-group>
        <journal-title>European Journal of Clinical Microbiology &amp; Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0934-9723</issn>
      <issn pub-type="epub">1435-4373</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20556465</article-id>
      <article-id pub-id-type="pmc">2963732</article-id>
      <article-id pub-id-type="publisher-id">999</article-id>
      <article-id pub-id-type="doi">10.1007/s10096-010-0999-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Campylobacter jejuni</italic> bacteremia and <italic>Helicobacter pylori</italic> in a patient with X-linked agammaglobulinemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>van den Bruele</surname>
            <given-names>T.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mourad-Baars</surname>
            <given-names>P. E. C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Claas</surname>
            <given-names>E. C. J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van der Plas</surname>
            <given-names>R. N.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuijper</surname>
            <given-names>E. J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bredius</surname>
            <given-names>R. G. M.</given-names>
          </name>
          <address>
            <phone>+31-71-5264131</phone>
            <fax>+31-71-5248198</fax>
            <email>R.G.M.Bredius@lumc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pediatrics, Leiden University Medical Center, P.O. Box&#xA0;9600, 2300 RC Leiden, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Medical Microbiology, Leiden University Medical Center, P.O. Box&#xA0;9600, 2300 RC Leiden, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>6</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>6</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <volume>29</volume>
      <issue>11</issue>
      <fpage>1315</fpage>
      <lpage>1319</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>3</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>5</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <p>We describe a 15-year-old patient with X-linked agammaglobulinemia who developed malabsorption and bacteremia due to infection of <italic>Helicobacter pylori</italic> and <italic>Campylobacter jejuni</italic>. The <italic>Campylobacter</italic> bacteremia was only recognized after subculturing of blood culture bottles that failed to signal in the automated system. After 2&#xA0;weeks of treatment with meropenem and erythromycin for 4&#xA0;weeks, the patient developed a relapse of bacteremia 10&#xA0;months later with a high level erythromycin resistant <italic>C. jejuni</italic>. Sequencing revealed an A2058C mutation in the 23 S rRNA gene associated with this resistance. Treatment with doxycycline for 4&#xA0;weeks finally resulted in complete eradication. This case report illustrates the importance for physicians to use adapted culture methods and adequate prolonged therapy in patients with an immunodeficiency. A summary of published case reports and series of patients with hypogammaglobulinemia or agammaglobulinemia with <italic>Campylobacter</italic> or <italic>Helicobacter</italic> bacteremia is given.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1007/s10096-010-0999-7) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2010</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by a mutation in the Bruton Tyrosine Kinase (<italic>BTK</italic>)-gene [<xref ref-type="bibr" rid="CR1">1</xref>]. This defect leads to abnormal development of B-lymphocytes and hypogammaglobulinemia. Patients with XLA usually present with recurrent bacterial infections, mainly of the respiratory and gastrointestinal tract. Other bacterial infections, like cellulitis, arthritis, meningitis and sepsis have also been described, but are less common. Various case reports mention a specific association of XLA patients and patients with acquired hypogammaglobulinemia with bacteremia caused by <italic>Helicobacter</italic> and <italic>Campylobacter</italic> species (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of published case reports<sup>a</sup> and series of patients with hypogammaglobulinemia or XLA with <italic>Campylobacter</italic> or <italic>Helicobacter</italic> bacteremia</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reference</th><th>Number of patients (age in years)</th><th>Disease</th><th>Micro-organisms, sites other than blood</th><th>Resistance</th><th>Symptoms</th><th>Treatment, duration (number of relapses of bacteremia)</th></tr></thead><tbody><tr><td>Le Bar et al. (1985)</td><td>2 (24, 36)</td><td>Hypo</td><td><italic>C. jejuni,</italic> Stool</td><td>NA</td><td>Fever, pneumonia, cellulitis</td><td>MC, AMG, 8 months (4), 6 months (1)</td></tr><tr><td>Spelman et al. (1986)</td><td>2 (25, 29)</td><td>XLA</td><td><italic>C. jejuni</italic></td><td>NA</td><td>Cellulitis, fever, ureter colics</td><td>MC, AMG, 6 months (2)</td></tr><tr><td>van der Meer et al. (1986)</td><td>1 (24)</td><td>XLA</td><td><italic>C. jejuni,</italic> Stool</td><td>NA</td><td>Fever</td><td>NA, &gt;1 year (NA)</td></tr><tr><td>Chusid et al. (1987)</td><td>1 (11)</td><td>XLA</td><td><italic>C. jejuni,</italic> Stool</td><td>NA</td><td>Malaise</td><td>PEN, AMG, 1 week (0)</td></tr><tr><td>Kerstens et al. (1992)</td><td>3 (26, 20, 24)</td><td>XLA, Hypo</td><td><italic>C. jejuni,</italic> Stool, skin</td><td>FQ</td><td>Cellulitis, fever, osteomyelitis</td><td>CA, MC, 1 ;month (1), 1 year (2), 1 year (2)</td></tr><tr><td>Borleffs et al. (1993)</td><td>2 (23, 25)</td><td>Hypo</td><td><italic>C. jejuni,</italic> Stool</td><td>NA</td><td>Cellulitis, fever</td><td>CA, FQ, i.v. IgM, 6 months (2), 6 months (3)</td></tr><tr><td>Simon et al. (1995)</td><td>1 (70)</td><td>Hypo</td><td><italic>C. jejuni</italic></td><td>NA</td><td>Arthritis, diarrhea</td><td>NA, Patient died</td></tr><tr><td>Autenrieth et al. (1996)</td><td>1 (7)</td><td>XLA</td><td><italic>C. jejuni</italic></td><td>NA</td><td>Cellulitis</td><td>FQ, maternal plasma, &gt;2&#xA0;years (NA)</td></tr><tr><td>Moore et al. (2001)</td><td>1 (NA)</td><td>Hypo</td><td><italic>C. jejuni,</italic> Stool</td><td>NA</td><td>Diarrhea</td><td>NA, 2 year (5)</td></tr><tr><td>Rafi and Matz (2002)</td><td>1 (32)</td><td>XLA</td><td><italic>C. jejuni,</italic> Stool, colon, pericardial fluid</td><td>NA</td><td>Pericardial tamponade, pneumonia</td><td>MC, FQ, NA</td></tr><tr><td>Tokuda et al. (2004)</td><td>1 (16)</td><td>XLA</td><td><italic>C. coli</italic></td><td>NA</td><td>Cellulitis</td><td>CA, AMG, 6 months (1)</td></tr><tr><td>Arai et al. (2007)</td><td>1 (35)</td><td>XLA</td><td><italic>C. coli,</italic> Stool</td><td>MC</td><td>Arthritis, fever</td><td>TET, CA, 1 year and 7 months (3)</td></tr><tr><td>Okada et al. (2008)</td><td>1 (33)</td><td>XLA</td><td><italic>C. coli</italic>, Intestinal biopsy</td><td>NA</td><td>Endocarditis, osteomyelitis</td><td>CA, FQ, TET, AMG, 8 months (4)</td></tr><tr><td>Chusid et al. (1990)</td><td>1 (16)</td><td>Hypo</td><td><italic>C. upsaliens</italic></td><td>NA</td><td>Fever</td><td>Ceph, 6 months (1)</td></tr><tr><td>Neuzil et al. (1994)</td><td>1 (50)</td><td>Hypo</td><td><italic>C. fetus</italic></td><td>NA</td><td>Osteomyelitis, cellulitis</td><td>CA, MC, 10 months (2)</td></tr><tr><td>Jirapongsananuruk et al. (2006)</td><td>1 (15)</td><td>XLA</td><td><italic>C. lari</italic></td><td>Ceph, FQ</td><td>Sinusitis, fever</td><td>AMC, MC, 9 months (3)</td></tr><tr><td>Weir et al. (1999)</td><td>1 (36)</td><td>XLA</td><td><italic>Flexispira rappini</italic></td><td>PEN, MC, Ceph, FQ</td><td>Cellulitis</td><td>AMG, CA, 3 years (NA)</td></tr><tr><td>Cuccherini et al. (2000)</td><td>2 (36, 21)</td><td>XLA</td><td><italic>Helicobacter, flexispera</italic>-like organism</td><td>Metr</td><td>Cellulitis, synovitis, fever, gastritis</td><td>AMG, CA, 1 year (NA)</td></tr><tr><td>Gerrard et al. (2001)</td><td>1 (27)</td><td>XLA</td><td><italic>H. canis, Flexispera rappini</italic></td><td>NA</td><td>Cellulitis, fever</td><td>TET, Metr, 2 months (1)</td></tr><tr><td>Simons et al. (2004 )</td><td>1 (54)</td><td>XLA</td><td><italic>H. cinaedi</italic></td><td>NA</td><td>Cellulitis</td><td>AMG, CA, 3 months (2)</td></tr><tr><td>van den Bruele, this paper</td><td>1 (15)</td><td>XLA</td><td><italic>C. jejuni, H. pylori,</italic> stool</td><td>MC</td><td>Fever, anorexia</td><td>CA, MC, TET, 10 months (1)</td></tr></tbody></table><table-wrap-foot><p><italic>XLA</italic> X-linked agammaglobulinemia, <italic>Hypo</italic> hypoagammaglobulinemia, <italic>NA</italic> not available, <italic>i.v. IgM</italic> intravenous immunoglobulin M, <italic>AMC</italic> amoxicillin/clavulanic acid, <italic>AMG</italic> aminoglycoside, <italic>CA</italic> carbapenem, <italic>Ceph</italic> cephalosporin, <italic>FQ</italic> fluoroquinolone, <italic>MC</italic> macrolide, <italic>Metr</italic> metronidazole, <italic>PEN</italic> penicillin, <italic>TET</italic> tetracycline</p><p><sup>a</sup> For the references of Table <xref rid="Tab1" ref-type="table">1</xref> refer to the <xref ref-type="sec" rid="AppESM1">supplemental material</xref></p></table-wrap-foot></table-wrap></p>
      <p>Recently, we treated a boy with XLA who developed fever, loss of appetite and failure to thrive caused by a combination of <italic>H. pylori</italic> gastritis and recurrent <italic>C. jejuni</italic> bacteremia.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>A 5-year-old Iranian boy with a history of recurrent infections and an absence of peripheral blood B-lymphocytes was diagnosed with XLA. The boy was living in The Netherlands since his fifth year. DNA analysis revealed a frame shift mutation (1614de1T) in exon 16 of the <italic>BTK</italic>-gene [<xref ref-type="bibr" rid="CR4">4</xref>]. He was treated with prophylactic co-trimoxazole and intravenous immunoglobulin (IVIG) substitution therapy every 4&#xA0;weeks. During the last 3&#xA0;years, IgG levels varied from 5.0 to 8.7&#xA0;g/L (normal range for IgG is 5.2&#x2013;15.0&#xA0;g/L). To reach a trough level of around 8&#xA0;g/L he required a high dosage of IVIG of 1.2&#xA0;g/kg [<xref ref-type="bibr" rid="CR5">5</xref>]. He had no detectable IgA and IgM. At the age of 10&#xA0;years he developed epilepsy caused by left occipital lesions, presumably acquired by infections in the past.</p>
      <p>At the age of 15&#xA0;years he was admitted to our hospital with progressive loss of appetite, initially ascribed to his anti-epileptic medication. He was severely malnourished (weight/length ratio &#x2212;3 Dutch standard deviation score, comparable to Iranian growth charts). Stool antigen test for <italic>H. pylori</italic> was positive. Endoscopy and biopsies of the gastric antrum, corpus and duodenum showed chronic active inflammation with atrophy and intestinal metaplasia. Cultures of the antrum and corpus were positive for <italic>H. pylori</italic> as well as for <italic>C. jejuni</italic>. Biopsies of anthrum and corpus were inoculated on non-selective blood agar media and onto specific <italic>H. pylori</italic> media (Pylori agar, Biom&#xE9;rieux, France) in a micro-aerophilic environment for 7&#xA0;days. Identification was performed by conventional biochemical reactions according to standard operation procedures [<xref ref-type="bibr" rid="CR6">6</xref>]. During hospitalization the patient had periods of fever. Laboratory tests showed an elevated C-reactive protein (up to 94&#xA0;U/L; normal &lt;5&#xA0;U/L). His leukocyte and neutrophil counts were always normal. Blood cultures revealed <italic>C. jejuni</italic>, sensitive for ciprofloxacin (MIC 0.032&#xA0;mg/L), erythromycin (MIC 0.75&#xA0;mg/L) and meropenem (MIC 0.012&#xA0;mg/L) as determined by <italic>E</italic>-testing (AB Biom&#xE9;rieux, Solna, Sweden). An identical strain was isolated from the patient&#x2019;s feces. Other pathogens were never detected from stool, throat, urine or spinal fluid; cultures or PCR tests were negative for enteric parasites, viruses including enteroviruses and pathogenic bacteria. The patient was treated with intravenous meropenem for 2 weeks, followed by oral erythromycin for another 4&#xA0;weeks. Repeated blood cultures after 10 days were negative. For eradication of <italic>H. pylori</italic> he additionally received triple therapy with amoxicillin, clarithromycin and omeprazol for one week. <italic>H. pylori</italic> was sensitive to erythromycin (MIC 0.38&#xA0;mg/L), clarithromycin (MIC 0.19&#xA0;mg/L) and meropenem (MIC 0.002&#xA0;mg/L).</p>
      <p>During follow-up he improved clinically and with tube feeding his weight increased to &#x2212;1 standard deviation score. Endoscopy was repeated 8 months later and showed much less inflammation of the gastric mucosa and absence of <italic>H. pylori</italic> in microscopy and culture of biopsies. However, from a fecal specimen a <italic>C. jejuni</italic> strain was isolated with secondary resistance to erythromycin (MIC &#x2265; 256&#xA0;mg/L) but persistent sensitivity to ciprofloxacin (MIC 0.125&#xA0;mg/L) and meropenem (MIC 0.008&#xA0;mg/L). Ten months later, he again developed a <italic>C. jejuni</italic> bacteremia. The strain had a similar pattern as the stool isolate, with high level resistance to erythromycin by <italic>E</italic>-testing (MIC &#x2265; 256&#xA0;mg/L), but the strain was sensitive to tetracycline. Sequence analysis of part of the 23S rRNA gene revealed an A2058C mutation (position of nucleotide reported as the <italic>Escherichia coli</italic> equivalent), known to be associated with erythromycin resistance [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The strain isolated 8&#xA0;weeks earlier from the feces did not have this mutation. No other pathogens were isolated. He again had complaints of loss of appetite, no diarrhea or skin lesions and some weight loss. Co-trimoxazole prophylactic therapy was switched to azithromycin (for 2&#xA0;weeks) and later to doxycycline (for 4&#xA0;weeks), which resulted in clinical improvement and negative stool and blood cultures at follow-up after 6&#xA0;months.</p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <p>In the primary antibody deficiency disorders such as XLA, enteropathogenic <italic>Helicobacter</italic> species and the closely related species <italic>Flexispira</italic> and <italic>Campylobacter</italic> can cause persistent gastrointestinal infections and bacteremia, as well as skin and bone infections [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In immunocompetent individuals bacteria are eliminated from the blood by antibody- and complement-mediated lysis. Patients with XLA form no or inadequate specific antibodies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Despite immunoglobulin substitution therapy with normal IgG levels (IgA and IgM antibodies remained absent), severe infections with <italic>Campylobacter</italic> and <italic>Helicobacter</italic> can emerge [<xref ref-type="bibr" rid="CR11">11</xref>]. Higher IgG through levels during immunoglobulin supplementation may lead to better protection [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>In the Netherlands the incidence of <italic>Campylobacter</italic> infections is 39 per 100,000 people per year (children and adults) [<xref ref-type="bibr" rid="CR12">12</xref>]. <italic>C. jejuni</italic> is the most frequently isolated pathogen of the <italic>Campylobacter</italic> species; <italic>C. coli, C. lari</italic> and <italic>C. upsaliensis</italic> are less frequently encountered pathogens. Transmission of <italic>C. jejuni</italic> occurs by ingestion of contaminated food (i.e. chicken and pork), water and unpasteurized milk. <italic>Helicobacter</italic> infections in children are acquired early in life, mainly via oral&#x2013;fecal contact. In the Netherlands, the prevalence of <italic>H. pylori</italic> in children is very low (1.2%); most infected children are offspring of non-Dutch parents like our patient [<xref ref-type="bibr" rid="CR13">13</xref>]. Our patient had a double infection, which may be coincidental but could also be based on his Iranian background. In Iran, the prevalence of <italic>H. pylori</italic> was reported to be 58% in healthy 15-year-old children [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Bacteremia with <italic>Campylobacter</italic> and <italic>Helicobacter</italic> species is frequently found in XLA patients. Winkelstein et al. [<xref ref-type="bibr" rid="CR2">2</xref>] found a prevalence of 10% in 21 septicemic patients from a series of 201 XLA patients. Recognition of bacteremia with <italic>Helicobacter</italic> and <italic>Campylobacter</italic> species is sometimes difficult, since <italic>Helicobacter</italic> and <italic>Campylobacter</italic> grow slowly in standard automatic blood culture systems. It is recommended to subculture blood culture bottles to solid media after one week of incubation when no signal of growth has appeared. In some microbiological laboratories this is a standard procedure for blood culture bottles from patients with endocarditis or from patients with hypogammaglobulinemia. In our patient the standard blood cultures were negative; only subculturing resulted in recognition of <italic>C. jejuni.</italic></p>
      <p>Symptoms, antibiotic treatment, antibiotic resistance, and duration of bacteremia of published cases are summarized in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. Twenty-six immunocompromised patients with bacteremia caused by <italic>Campylobacter</italic> or <italic>Helicobacter</italic> species have been described in the literature; only five of these cases were children (&lt;18&#xA0;years of age). Remarkably, diarrhea or other gastrointestinal complaints are not always present (33&#x2013;37%) [<xref ref-type="bibr" rid="CR9">9</xref>]. Erysipelas-like cellulitis was present in 11 of 26 patients (40%); it mostly disappears within several days after start of antibiotic therapy but is an important early clinical sign for <italic>Helicobacter</italic> or <italic>Campylobacter</italic> bacteremia. Five of 25 patients (20%) had septic arthritis or osteomyelitis, which is remarkably high; others described an incidence of, respectively, 7% and 3% in 201 patients with XLA [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>Most patients needed prolonged antibiotic therapy to eradicate the microorganisms, with a mean duration of approximately 10&#xA0;months (ranging from 1&#xA0;week to 3&#xA0;years). Our patient presented with fever, malaise and anorexia. He had a long lasting and recurrent bacteremia, which almost exclusively appears in immunocompromised patients.</p>
      <p>In immunocompetent individuals, <italic>H. pylori</italic> remains a superficial chronic gastritis, with a small percentage of individuals progressing to duodenal or gastric ulcers and rarely to gastrointestinal malignancies. Common variable immunodeficiency patients have an almost 50-fold increased risk for gastric cancer and a 30-fold increased risk for lymphoma [<xref ref-type="bibr" rid="CR11">11</xref>]. The patient we described did not develop a relapse or recurrent <italic>H. pylori</italic> infection.</p>
      <p>Antibiotic resistance of <italic>Campylobacter</italic> species to fluoroquinolones and macrolides is increasing. In The Netherlands, resistance to fluoroquinolones and macrolides is up to 35% and 2.7% of the isolates, respectively [<xref ref-type="bibr" rid="CR12">12</xref>]. However, the latter may be overestimated, since phenotypical routine susceptibility tests for erythromycin are difficult to interpret [<xref ref-type="bibr" rid="CR15">15</xref>]. Most <italic>Campylobacter</italic> isolates are sensitive for amoxicillin-clavulanic acid (resistance rate 1&#x2013;2%) [<xref ref-type="bibr" rid="CR9">9</xref>]. The strain of our patient had high-level resistance to erythromycin (MIC &#x2265; 256&#xA0;mg/L). Because of reported difficulties in the phenotypic recognition of erythromycin resistant isolates, the presence of the erythromycin resistant <italic>C. jejuni</italic> was confirmed by 23S rRNA gene sequence; analysis revealed an A2058C mutation [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. <italic>Campylobacter</italic> isolates displaying resistance to erythromycin usually have resistance-associated mutations at position 2058 and/or 2059 of the 23S rRNA gene. They lead to cross-resistance to macrolide and lincosamide antibiotics. No resistance has been described for carbapenem antibiotics, such as meropenem [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>The mortality of inadequately treated bacteremia is estimated to be around 2.5&#x2013;5.5% [<xref ref-type="bibr" rid="CR9">9</xref>]. The mean duration of treatment of bacteremia is 10 to 14&#xA0;days in immunocompetent individuals. In immunocompromised patients longer treatment may be necessary. Also, in our patient the <italic>Campylobacter</italic> was hard to eradicate. He received 2 weeks intravenous treatment with meropenem, followed by 4 weeks erythromycin with apparently good effect. However, despite changes of antibiotic treatment <italic>C. jejuni</italic> remained detectable in his stool cultures, and later on he had a relapse of bacteremia. After a 4-week course of doxycycline, <italic>C. jejuni</italic> could be eradicated.</p>
      <p>In conclusion, multiple infections can be encountered in patients with XLA that present with vague symptoms such as failure to thrive, weight loss or anorexia and fever. Bacteremia with the <italic>Campylobacter</italic> species is hard to detect and needs specific laboratory expertise. In patients with agammaglobulinemia, <italic>Campylobacter</italic> eradication can only be achieved with adequate antibiotic therapy and prolonged treatment; <italic>H. pylori</italic> seems easier to eliminate.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <sec id="AppESM1">
        <title>Electronic supplementary material</title>
        <supplementary-material id="d28e1180" content-type="local-data">
          <p>Below is the link to the electronic supplementary material.
</p>
          <media xlink:href="10096_2010_999_MOESM1_ESM.doc" id="MOESM1" mimetype="application" mime-subtype="msword">
            <label>ESM 1</label>
            <caption>
              <p>(DOC 25 kb)</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>The authors wish to thank Ms. A. de Hullu for nutritional support of the patient throughout the disease course.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conley</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Broides</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hernandez-Trujillo</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kanegane</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyawaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shurtleff</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Genetic analysis of patients with defects in early B-cell development</article-title>
          <source>Immunol Rev</source>
          <year>2005</year>
          <volume>203</volume>
          <fpage>216</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0105-2896.2005.00233.x</pub-id>
          <pub-id pub-id-type="pmid">15661032</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winkelstein</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Lederman</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Burks</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Conley</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Cunningham-Rundles</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ochs</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
          <article-title>X-linked agammaglobulinemia: report on a United States registry of 201 patients</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2006</year>
          <volume>85</volume>
          <fpage>193</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1097/01.md.0000229482.27398.ad</pub-id>
          <pub-id pub-id-type="pmid">16862044</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freeman</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Persistent bacterial infections and primary immune disorders</article-title>
          <source>Curr Opin Microbiol</source>
          <year>2007</year>
          <volume>10</volume>
          <fpage>70</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mib.2006.11.005</pub-id>
          <pub-id pub-id-type="pmid">17208513</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansen</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Noordzij</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Brocker-Vriends</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Dongen</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Tol</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bredius</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Widely divergent clinical phenotype of X-linked agammaglobulinemia in two cousins</article-title>
          <source>Ned Tijdschr Geneeskd</source>
          <year>2004</year>
          <volume>148</volume>
          <fpage>1053</fpage>
          <lpage>1056</lpage>
          <pub-id pub-id-type="pmid">15185441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eijkhout</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Meer</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Kallenberg</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Weening</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Dissel</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Strengers</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Nienhuis</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schellekens</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial</article-title>
          <source>Ann Intern Med</source>
          <year>2001</year>
          <volume>135</volume>
          <fpage>165</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">11487483</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Landry</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Pfaller</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <source>Manual of clinical microbiology</source>
          <year>2007</year>
          <publisher-loc>Washington</publisher-loc>
          <publisher-name>ASM Press</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuijper</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imamura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wever</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Claas</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Genotypic identification of erythromycin-resistant campylobacter isolates as helicobacter species and analysis of resistance mechanism</article-title>
          <source>J Clin Microbiol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>3732</fpage>
          <lpage>3736</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.41.8.3732-3736.2003</pub-id>
          <pub-id pub-id-type="pmid">12904383</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ladely</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Meinersmann</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Englen</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Fedorka-Cray</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>23S rRNA gene mutations contributing to macrolide resistance in <italic>Campylobacter jejuni</italic> and <italic>Campylobacter coli</italic></article-title>
          <source>Foodborne Pathog Dis</source>
          <year>2009</year>
          <volume>6</volume>
          <fpage>91</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1089/fpd.2008.0098</pub-id>
          <pub-id pub-id-type="pmid">19014274</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pacanowski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lalande</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lacombe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boudraa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lesprit</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Legrand</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Trystram</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kassis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Arlet</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mainardi</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Doucet-Populaire</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Girard</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Meynard</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title><italic>Campylobacter</italic> bacteremia: clinical features and factors associated with fatal outcome</article-title>
          <source>Clin Infect Dis</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>790</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="doi">10.1086/591530</pub-id>
          <pub-id pub-id-type="pmid">18699745</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miyanohara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sarantuya</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Iwashita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kamenosono</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hizukuri</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wakimoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yoshinaga</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Relapsing cellulitis associated with <italic>Campylobacter coli</italic> bacteremia in an agammaglobulinemic patient</article-title>
          <source>Pediatr Infect Dis J</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>577</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="doi">10.1097/01.inf.0000130080.86862.d5</pub-id>
          <pub-id pub-id-type="pmid">15194845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desar</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Deuren</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sprong</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jansen</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Namavar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vandenbroucke-Grauls</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Meer</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Serum bactericidal activity against <italic>Helicobacter pylori</italic> in patients with hypogammaglobulinaemia</article-title>
          <source>Clin Exp Immunol</source>
          <year>2009</year>
          <volume>156</volume>
          <fpage>434</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.03909.x</pub-id>
          <pub-id pub-id-type="pmid">19438595</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hees</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Veldman-Ariesen</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Jongh</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Tersmette</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pelt</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Regional and seasonal differences in incidence and antibiotic resistance of <italic>Campylobacter</italic> from a nationwide surveillance study in The Netherlands: an overview of 2000&#x2013;2004</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>305</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01643.x</pub-id>
          <pub-id pub-id-type="pmid">17391386</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mourad-Baars</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Verspaget</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Mearin</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Low prevalence of <italic>Helicobacter pylori</italic> infection in young children in the Netherlands</article-title>
          <source>Eur J Gastroenterol Hepatol</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>213</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1097/MEG.0b013e328011050f</pub-id>
          <pub-id pub-id-type="pmid">17301647</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alborzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Soltani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pourabbas</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Oboodi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Haghighat</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayati</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rashidi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of <italic>Helicobacter pylori</italic> infection in children (south of Iran)</article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2006</year>
          <volume>54</volume>
          <fpage>259</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2005.10.012</pub-id>
          <pub-id pub-id-type="pmid">16466888</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beek</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Claas</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Mevius</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Pelt</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wagenaar</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kuijper</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>51</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02755.x</pub-id>
          <pub-id pub-id-type="pmid">19438640</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
